A subscription to JoVE is required to view this content. Sign in or start your free trial.
The rat heterotopic auxiliary liver transplant protocol described here offers a practical investigational tool for exploring mechanisms of hepatic allograft rejection. This model helps to alleviate the surgical hurdles and animal stress of orthotopic liver transplantation in rats.
Small animal transplant models are indispensable for organ tolerance studies investigating feasible therapeutic interventions in preclinical studies. Rat liver transplantation (LTx) protocols typically use an orthotopic model where the recipients' native liver is removed and replaced with a donor liver. This technically demanding surgical procedure requires advanced micro-surgical skills and is further complicated by lengthy anhepatic and lower body ischemia times. This prompted the development of a less complicated heterotopic method that can be performed faster with no anhepatic or lower body ischemia time, reducing post-surgery stress for the recipient animal.
This heterotopic LTx protocol includes two main steps: excising the liver from the donor rat and transplanting the whole liver into the recipient rat. During the excision of the donor liver, the surgeon ligates the supra-hepatic vena cava (SHVC) and hepatic artery (HA). On the recipient side, the surgeon removes the left kidney and positions the donor liver with the portal vein (PV), infra-hepatic vena cava (IHVC), and bile duct facing the renal vessels. Further, the surgeon anastomoses the recipient's renal vein end to end with the IHVC of the liver and arterializes the PV with the renal artery using a stent. A hepaticoureterostomy is utilized for biliary drainage by anastomosing the bile duct to the recipient's ureter, permitting the discharge of bile via the bladder.
The average duration of the transplantation was 130 min, cold ischemia duration was around 35 min, and warm ischemia duration was less than 25 min. Hematoxylin and eosin histology of the auxiliary liver from syngeneic transplants showed normal hepatocyte structure with no significant parenchymal alterations 30 days post-transplant. In contrast, 8-day post-transplant allogeneic graft specimens demonstrated extensive lymphocytic infiltration with a Banff Schema rejection activity index score of 9. Therefore, this LTx method facilitates a low morbidity rejection model alternative to orthotopic LTx.
Small animal LTx is an invaluable model for investigating mechanisms of liver rejection. Heterotopic auxiliary liver transplantation with portal vein arterialization (HALT-PVA) in rats was introduced in 1968 by Lee and Edgington1when they reported using a recipient's renal vein and artery to re-vascularize a grafted auxiliary liver. Subsequently, Hess et al.2 enhanced the protocol with the mitigation of functional competition between the native and auxiliary livers by reducing the native and donor liver size along with reconstructing the donor bile duct connection, resulting in long-term graft survival. Further refin....
Animals were bred and housed in specific pathogen-free conditions in the animal care facilities at the University of Wisconsin (UW)-Madison Institute for Medical Research in accordance with institutional guidelines. The study protocol (No. M006022) was approved by the Institutional Animal Care and Use Committee at the UW School of Medicine and Public Health, and all animals were treated ethically.
1. Animals
Presently, 29 pairs of rats have been used to establish the HALT-PVA protocol, 17 syngeneic transplants, and 12 allogeneic transplants. The syngeneic transplanted livers survived to their designated 8 or 30-day experimental endpoint with a 70% success rate, while allogeneic transplanted livers survived to their designated 3 or 8-day endpoints with a 50% success rate. Failures include rats that died due to surgical complications and auxiliary livers that failed even when the recipient survived.
Liver transplantation is the only treatment option for patients with end-stage liver disease, with almost 9,000 LTxs performed yearly in the US13. Unfortunately, immunological rejection is seen in up to 25% of LTx recipients, and this rejection is detrimental to the transplanted organ and patient14,15. To improve outcomes after LTx, the development of innovative models to study organ rejection and implement strategies to decrease rejection.......
This research was supported by the National Institute of Health (NIH) K08AI155816, awarded to DA.
....Name | Company | Catalog Number | Comments |
3-0 Silk Suture | Ethicon | C013D | |
5-0 Silk ties | Fine Science Tools | 18020-50 | |
6-0 Silk ties | Fine Science Tools | 18020-60 | |
7-0 Silk ties | Teleflex | 103-s | |
9-0 Polyamide Suture | AROSurgical | T05A09N10-13 | Black |
Bipolar Cautery | Codman & Shurtleff Inc. | P.H. 234 | |
Buprenorphine HCL | Hospira | 409201232 | |
Forceps, Adson-Brown | Fine Science Tools | 11627-12 | 12.5 cm |
Forceps, Angled Dumont | Fine Science Tools | 11253-25 | Medical #5/45 11 cm |
Forceps, Suture Tying | Fine Science Tools | 18025-10 | 10 cm |
Heparin Sodium Injection, USB | Fresenius Kabi | 504015 | 10,000 USP units per 10 mL |
Hydrodissection Cannula | Ambler Surgical | 1021E | 27 G |
Isoflurane | Dechra Vet. Products | 17033-091-25 | |
I.V. Catheter | Kendall | 2619PUR | 26 G x 3/4" |
Magnetic Retraction System | Fine Science Tools | 18200-50 | |
Micro Clamps | Fine Science Tools | 18055-05 | 6 mm |
Micro Clamps | Fine Science Tools | 18055-06 | 4 mm |
Micro Clamp Applicator | Fine Science Tools | 18057-14 | 14 cm |
Micro Needle Holder | S&T | C-14 | 14 cm |
Microscope | Zeiss | Universal S3 | Dual head |
Ophthalmic Ointment | Puralube | 14590500 | |
Polyimidi Tubing | Cole Parmer | 95820-04 | OD 0.0215", ID 0.0195", wall 0.0010" |
Saline | Baxter | 281324 | 0.9% Sodium Chloride |
Surgical Spring Scissors | S&T | SDC-15 | Blunt 14 cm |
Surgical Spring Scissors | Fine Science Tools | 15021-15 | Vannas 14 cm |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved